Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Watchlist Manager
Jiangsu Hengrui Pharmaceuticals Co Ltd Logo
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Watchlist
Price: 48.27 CNY -4.34% Market Closed
Market Cap: 306.5B CNY
Have any thoughts about
Jiangsu Hengrui Pharmaceuticals Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Jiangsu Hengrui Pharmaceuticals Co Ltd

Revenue
26B CNY
Cost of Revenue
-3.9B CNY
Gross Profit
22.1B CNY
Operating Expenses
-16.2B CNY
Operating Income
5.8B CNY
Other Expenses
-392m CNY
Net Income
5.4B CNY

Income Statement
Jiangsu Hengrui Pharmaceuticals Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
7 156
N/A
7 452
+4%
7 935
+6%
8 328
+5%
8 833
+6%
9 316
+5%
9 781
+5%
10 209
+4%
10 709
+5%
11 094
+4%
11 595
+5%
12 159
+5%
12 896
+6%
13 836
+7%
14 523
+5%
15 252
+5%
16 228
+6%
17 418
+7%
18 528
+6%
19 683
+6%
21 904
+11%
23 289
+6%
23 849
+2%
24 571
+3%
25 757
+5%
27 735
+8%
29 137
+5%
29 723
+2%
28 521
-4%
25 906
-9%
24 455
-6%
22 836
-7%
21 652
-5%
21 275
-2%
21 289
+0%
22 216
+4%
22 344
+1%
22 820
+2%
23 325
+2%
25 252
+8%
25 995
+3%
Gross Profit
Cost of Revenue
(1 373)
(1 316)
(1 499)
(1 491)
(1 521)
(1 372)
(1 555)
(1 561)
(1 611)
(1 433)
(1 686)
(1 813)
(1 946)
(1 851)
(2 221)
(2 302)
(2 430)
(2 338)
(2 706)
(2 839)
(3 038)
(2 918)
(3 199)
(3 173)
(3 378)
(3 356)
(3 782)
(3 993)
(3 918)
(3 756)
(3 882)
(3 865)
(3 871)
(3 503)
(3 682)
(3 775)
(3 685)
(3 562)
(3 835)
(3 854)
(3 930)
Gross Profit
5 783
N/A
6 137
+6%
6 436
+5%
6 837
+6%
7 312
+7%
7 944
+9%
8 226
+4%
8 648
+5%
9 098
+5%
9 661
+6%
9 908
+3%
10 346
+4%
10 950
+6%
11 984
+9%
12 303
+3%
12 950
+5%
13 798
+7%
15 080
+9%
15 821
+5%
16 845
+6%
18 866
+12%
20 370
+8%
20 650
+1%
21 398
+4%
22 379
+5%
24 379
+9%
25 355
+4%
25 730
+1%
24 602
-4%
22 150
-10%
20 573
-7%
18 971
-8%
17 781
-6%
17 772
0%
17 607
-1%
18 441
+5%
18 659
+1%
19 257
+3%
19 490
+1%
21 398
+10%
22 066
+3%
Operating Income
Operating Expenses
(4 180)
(4 446)
(4 570)
(4 805)
(5 119)
(5 532)
(5 682)
(6 006)
(6 329)
(6 819)
(6 911)
(7 163)
(7 588)
(8 256)
(8 409)
(8 871)
(9 509)
(10 852)
(11 341)
(12 106)
(13 778)
(14 705)
(14 837)
(15 460)
(16 064)
(17 916)
(18 711)
(19 174)
(18 191)
(18 118)
(16 896)
(15 818)
(15 237)
(14 215)
(14 462)
(15 014)
(15 049)
(14 724)
(14 722)
(15 614)
(16 225)
Selling, General & Administrative
(4 179)
(3 750)
(4 558)
(4 788)
(5 107)
(4 591)
(5 675)
(6 000)
(6 327)
(5 588)
(6 914)
(7 168)
(7 576)
(6 599)
(8 574)
(9 034)
(8 953)
(8 303)
(9 117)
(9 151)
(10 134)
(10 959)
(10 992)
(11 337)
(11 900)
(13 104)
(13 425)
(13 660)
(12 632)
(12 380)
(11 588)
(10 659)
(10 327)
(9 833)
(9 559)
(10 144)
(10 120)
(10 083)
(10 118)
(10 381)
(10 887)
Research & Development
0
(652)
0
0
0
(892)
0
0
0
(1 184)
0
0
0
(1 759)
0
0
(741)
(2 527)
(2 337)
(3 159)
(3 834)
(3 661)
(4 046)
(4 276)
(4 341)
(4 821)
(5 494)
(5 706)
(5 787)
(5 745)
(5 634)
(5 547)
(5 299)
(4 662)
(5 028)
(5 034)
(5 115)
(4 662)
(5 025)
(5 660)
(5 777)
Depreciation & Amortization
0
(43)
0
0
0
(48)
0
0
0
(45)
0
0
0
(51)
0
0
0
(191)
0
0
0
(272)
0
0
0
(196)
0
0
0
(260)
0
0
0
(263)
0
0
0
(405)
0
0
0
Other Operating Expenses
(1)
(1)
(12)
(17)
(12)
(1)
(7)
(7)
(2)
(2)
4
5
(11)
154
165
163
185
167
113
204
189
187
201
153
177
207
208
191
228
267
326
388
389
542
125
163
185
426
422
426
439
Operating Income
1 603
N/A
1 690
+5%
1 866
+10%
2 032
+9%
2 194
+8%
2 412
+10%
2 544
+5%
2 641
+4%
2 769
+5%
2 842
+3%
2 997
+5%
3 184
+6%
3 363
+6%
3 729
+11%
3 894
+4%
4 079
+5%
4 289
+5%
4 228
-1%
4 481
+6%
4 739
+6%
5 088
+7%
5 666
+11%
5 813
+3%
5 938
+2%
6 315
+6%
6 463
+2%
6 644
+3%
6 556
-1%
6 411
-2%
4 032
-37%
3 677
-9%
3 154
-14%
2 544
-19%
3 557
+40%
3 145
-12%
3 426
+9%
3 610
+5%
4 533
+26%
4 768
+5%
5 784
+21%
5 840
+1%
Pre-Tax Income
Interest Income Expense
73
82
98
107
111
147
160
167
178
182
165
170
170
77
130
168
234
367
351
421
451
483
544
583
569
541
549
423
471
629
549
682
699
649
939
849
782
444
430
538
473
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
(1)
0
(1)
0
2
2
2
3
2
2
2
2
1
1
1
1
3
3
4
5
2
3
1
1
(94)
6
9
10
(67)
4
3
1
Gain/Loss on Disposition of Assets
(0)
0
(5)
(5)
(5)
(6)
(2)
(2)
(2)
0
(0)
0
2
(1)
0
0
0
(1)
0
0
0
(2)
0
0
0
(2)
0
0
0
0
0
0
0
(1)
0
0
0
(6)
0
0
0
Total Other Income
26
28
26
25
26
9
10
8
6
(10)
(7)
(5)
(2)
(48)
(56)
(75)
(96)
(97)
(108)
(121)
(107)
(92)
(109)
(137)
(190)
(109)
(110)
(120)
(104)
(197)
(171)
(146)
(172)
(142)
(163)
(154)
(155)
(237)
(357)
(418)
(372)
Pre-Tax Income
1 701
N/A
1 800
+6%
1 984
+10%
2 158
+9%
2 325
+8%
2 562
+10%
2 712
+6%
2 814
+4%
2 951
+5%
3 013
+2%
3 155
+5%
3 348
+6%
3 532
+6%
3 759
+6%
3 970
+6%
4 175
+5%
4 430
+6%
4 499
+2%
4 726
+5%
5 042
+7%
5 434
+8%
6 056
+11%
6 250
+3%
6 386
+2%
6 695
+5%
6 895
+3%
7 086
+3%
6 863
-3%
6 783
-1%
4 466
-34%
4 059
-9%
3 691
-9%
3 071
-17%
3 968
+29%
3 928
-1%
4 129
+5%
4 247
+3%
4 667
+10%
4 845
+4%
5 906
+22%
5 941
+1%
Net Income
Tax Provision
(205)
(227)
(253)
(284)
(305)
(338)
(363)
(355)
(387)
(379)
(397)
(441)
(459)
(466)
(512)
(531)
(569)
(438)
(444)
(512)
(593)
(729)
(811)
(820)
(859)
(587)
(587)
(544)
(525)
18
137
199
317
(153)
(88)
(92)
(77)
(389)
(433)
(491)
(498)
Income from Continuing Operations
1 496
1 573
1 732
1 875
2 021
2 224
2 349
2 459
2 564
2 634
2 759
2 907
3 073
3 293
3 459
3 644
3 862
4 061
4 282
4 530
4 841
5 326
5 439
5 566
5 836
6 309
6 499
6 319
6 258
4 484
4 196
3 890
3 388
3 815
3 840
4 037
4 170
4 278
4 412
5 416
5 443
Income to Minority Interest
(67)
(57)
(59)
(58)
(50)
(52)
(40)
(34)
(36)
(45)
(42)
(59)
(85)
(76)
(104)
(91)
(61)
4
27
38
47
2
12
12
16
19
10
15
19
46
74
92
108
91
68
58
37
25
20
10
5
Net Income (Common)
1 429
N/A
1 516
+6%
1 673
+10%
1 817
+9%
1 970
+8%
2 172
+10%
2 309
+6%
2 425
+5%
2 529
+4%
2 589
+2%
2 717
+5%
2 848
+5%
2 988
+5%
3 217
+8%
3 354
+4%
3 553
+6%
3 801
+7%
4 066
+7%
4 309
+6%
4 568
+6%
4 889
+7%
5 328
+9%
5 451
+2%
5 577
+2%
5 852
+5%
6 328
+8%
6 510
+3%
6 334
-3%
6 277
-1%
4 530
-28%
4 271
-6%
3 982
-7%
3 496
-12%
3 906
+12%
3 908
+0%
4 095
+5%
4 207
+3%
4 302
+2%
4 432
+3%
5 426
+22%
5 448
+0%
EPS (Diluted)
0.23
N/A
0.24
+4%
0.27
+13%
0.29
+7%
0.31
+7%
0.41
+32%
0.38
-7%
0.4
+5%
0.42
+5%
0.41
-2%
0.43
+5%
0.45
+5%
0.47
+4%
0.51
+9%
0.53
+4%
0.56
+6%
0.6
+7%
0.64
+7%
0.68
+6%
0.72
+6%
0.77
+7%
0.84
+9%
0.86
+2%
0.88
+2%
0.92
+5%
1
+9%
1.03
+3%
1
-3%
1
N/A
0.71
-29%
0.67
-6%
0.62
-7%
0.55
-11%
0.61
+11%
0.62
+2%
0.64
+3%
0.68
+6%
0.68
N/A
0.7
+3%
0.85
+21%
0.85
N/A

See Also

Discover More